The 20 Best Marginal Zone Lymphoma (MZL) Doctors Near Me in darby, PA

Stefan Barta is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Barta is rated as an Elite provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Barta is board certified in Medical Oncology, 2010 and Hematology, 2010. Dr. Barta is currently accepting new patients.

Jacob Dubroff is a Nuclear Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Dubroff is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His clinical expertise encompasses Lung Nodules, Classical Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Dubroff is board certified in American Board Of Nuclear Medicine.

Victor Babatunde is a Radiologist and a Nuclear Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Babatunde is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His clinical expertise encompasses Classical Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Lung Nodules, Neuroendocrine Tumor, and Small Bowel Resection. Dr. Babatunde is board certified in American Board Of Radiology and American Board Of Nuclear Medicine. Dr. Babatunde is currently accepting new patients.

Jonathan Gefen is a General Surgeon practicing medicine in Wynnewood, Pennsylvania. Dr. Gefen is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Hernia, Cholecystitis, Gallbladder Disease, Hernia Surgery, and Gallbladder Removal.

Sunita Nasta is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Nasta is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 43 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Nasta is board certified in Hematology, 2002 and Medical Oncology, 2001. Dr. Nasta is currently accepting new patients.

Ellen Kim is a Dermatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Sezary Syndrome. Dr. Kim is board certified in Dermatology, 2000. Dr. Kim is currently accepting new patients.

Alain Rook is a Dermatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Rook is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome. Dr. Rook is board certified in Nephrology, 1980, Dermatology, 1991, and Internal Medicine, 1979. Dr. Rook is currently accepting new patients.

Henry Fung is a Hematologist Oncology specialist and a Transplant Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Fung is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Daniel Landsburg is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Landsburg is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Landsburg is board certified in Medical Oncology, 2014. Dr. Landsburg is currently accepting new patients.

Jennifer Villasenor-Park is a Dermatologist practicing medicine in Philadelphia, Pennsylvania. She has been practicing medicine for over 17 years. Dr. Villasenor-Park is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Lymphocytic Infiltrate of Jessner. Dr. Villasenor-Park is board certified in Dermatology, 2013. Dr. Villasenor-Park is currently accepting new patients.

Peter Merkel is a Rheumatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Merkel is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Merkel is board certified in Rheumatology, 1994. Dr. Merkel is currently accepting new patients.

Arthur Feldman is a Hematologist and an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Feldman is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Essential Thrombocythemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. Dr. Feldman is board certified in Medical Oncology, 1979. Dr. Feldman is currently accepting new patients.

Shubhasree Banerjee is a Rheumatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Banerjee is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Relapsing Polychondritis, Temporal Arteritis, Giant Cell Arteritis (GCA), and Juvenile Temporal Arteritis. Dr. Banerjee is board certified in Internal Medicine, 2013 and Rheumatology, 2016. Dr. Banerjee is currently accepting new patients.

Pierluigi Porcu is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Porcu is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, and Bone Marrow Aspiration.

Michael Walker is a Thoracic Surgeon practicing medicine in Media, Pennsylvania. Dr. Walker is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Lung Nodules, Thymectomy, and Advanced Bronchoscopy.

Karim Al-Sabek is a primary care provider, practicing in Internal Medicine in Darby, Pennsylvania. Dr. Al-Sabek is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, Viral Gastroenteritis, Gastrostomy, and Bone Marrow Aspiration. Dr. Al-Sabek is board certified in American Board Of Internal Medicine. Dr. Al-Sabek is currently accepting new patients.

Hiral Fontanilla is a Radiation Oncologist practicing medicine in Darby, Pennsylvania. Dr. Fontanilla is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma. Dr. Fontanilla is board certified in American Board Of Radiology, Radiation Oncology, 2013, and Radiation Oncology, American Board Of Radiology. Dr. Fontanilla is currently accepting new patients.

Jakub Svoboda is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Svoboda is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Classical Hodgkin Lymphoma, B-Cell Lymphoma, and Bone Marrow Aspiration.

Stephen Schuster is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Schuster is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Schuster is board certified in Hematology, 1986, Internal Medicine, 1984, and Medical Oncology, 1989. Dr. Schuster is currently accepting new patients.

Adam Cohen is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Primary Amyloidosis, and Bone Marrow Aspiration. Dr. Cohen is board certified in Hematology, 2007 and Medical Oncology, 2005. Dr. Cohen is currently accepting new patients.